Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results

P Pfeiffer, B Glimelius, S Winther, C Qvortrup, M Yilmaz, À Berglund, K Vistisen, C Kersten, G Liposits, H Sorbye

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerO 015
TidsskriftAnnals of Oncology
Vol/bind30
Udgave nummerSuppl. 4
Sider (fra-til)iv131
Antal sider1
ISSN0923-7534
DOI
StatusUdgivet - jul. 2019
Begivenhed21st World Congress on Gastrointestinal Cancer - Barcelona, Spanien
Varighed: 3. jul. 20196. jul. 2019

Konference

Konference21st World Congress on Gastrointestinal Cancer
Land/OmrådeSpanien
ByBarcelona
Periode03/07/201906/07/2019

Citationsformater